Similarly to Dox-treated STS, expression of phosphorylated AKT significantly increased in eribulin-treated STS, thereby revealing AKT phosphorylation a common compensatory mechanism counteracting the cytotoxic and anti-proliferative effects of chemotherapeutic agents used for therapy of patients with STS. Here, AKT1 is linked to telomere syndrome.